SightfileU.S. market data from official filings

Companies › BTAI

BioXcel Therapeutics Inc (BTAI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001720893 · EDGAR filings · Updated 2026-07-06

BioXcel Therapeutics Inc (BTAI) has reported institutional ownership of 20.1%, with 39 institutional managers holding positions valued at $7.27M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
20.1%
Institutional managers
39
Reported 13F value
$7.27M
Insider activity
46 trans.
$0 net flat
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BioXcel Therapeutics Inc has 39 institutional holders and institutional ownership of 20.1%.

Insider activity

Insiders reported 46 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2020-03-09) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-03-21 (recurring since 2024-09-20) — source filing. The authoritative details are those stated in the filing itself.

Related companies

MediciNova Inc (MNOV) · BIOHARVEST SCIENCES INC (BHST) · CINGULATE INC (CING) · Koninklijke Philips NV (PHG) · NEUPHORIA THERAPEUTICS IN (NEUP) · Kyntra Bio Inc (KYNB)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.